• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

April 4, 2023

Study: Financial, Time-Related Burdens Hurt Quality of Life of Those With Gynecologic Cancer

Author(s):

Ashley Gallagher, Editor
Conference|SGO Annual Meeting on Women’s Cancer - Society of Gynecologic Oncology Annual Meeting on Women’s Cancer

Investigators suggest that funding mechanisms and interpersonal support systems are unsustainable for long-term care.

Senior Woman Undergoing Chemotherapy With Nurse | Image Credit: Monkey Business - stock.adobe.com

Monkey Business - stock.adobe.com

Financial and time-related burdens not only negatively affect individuals with gynecologic cancer but quality of life (QOL) as well, according to the results of 2 studies presented at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.

SGO is a specialty medical association for health care professionals who are trained in the management of gynecological cancers.

In the first study presented, investigators examined treatment-related time burden among 75 women who have advanced or recurrent endometrial cancer to determine time-related QOL and time-related toxicity between treatment courses. The median age was 67 years, with 51% of individuals being white, 41% Black, and 8% being another ethnicity or race.

“Patient-centered outcomes are important to consider as we make difficult treatment decisions in the recurrent setting,” Sarah Ackroyd, MD, MPH, an investigator said in a statement.

“Time toxicity is a potential new outcome measure that can help us understand the treatment-related time demands our patients' experience,” she said. “I hope that this framework can be further developed and used to improve the workflow of cancer care and the [QOL] of our patients.”

Investigators found that women who had advanced or recurrent endometrial cancer spent more time tending to their needs during treatment. Additionally, they found it was correlated with worse QOL scores.

In the second study, investigators examined the financial and social impact of ovarian cancer care, as well as strategies implemented by patients and their support systems. They included 40 individuals with recurrent advanced-stage ovarian cancer, who participated in qualitative interviews about their financial experiences and how it affected their care. Individuals had a median age of 59.3 years, and the median time from diagnosis was 44.7 months.

The individuals reported that they cut back on leisure activities and necessities, because of their health care.

They also said that financial and social support was received through crowdsourcing strategies and social networks to help fund their care.

“Participants in our study had health insurance and were receiving care at a comprehensive cancer center, yet they reported significant financial distress, causing them to lose their employment, insurance, homes, and other assets,” Naomi Adjei, MD, MPH, MSEd, an investigator, said in the statement.

“How are cancer patients in less-affluent settings with fewer safety nets coping? Policies and interventions that promote timely cancer care accessibility, innovative insurance models, and value-based care will protect patients, their families, and their interpersonal social networks, as well as ensure more sustainable health care spending by the US health care system,” Adjei said.

Investigators suggested that funding mechanisms and interpersonal support systems are unsustainable for long-term care and called on more reliable systems for patients to alleviate cancer-related financial distress.

Reference

Gynecologic cancer patients report time-related burdens and financial toxicities impact quality of life. Society of Gynecologic Oncology. News release. March 26, 2023. Accessed March 27, 2023. Email.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Related Content
Advertisement
Close up,asian female doctor with syringe doing injection vaccine,flu,influenza in the shoulder of senior woman, nurse injecting,vaccinating elderly patient,vaccination,medicine,health care concept
August 24th 2025

Patients Express Confidence in Pneumococcal Vaccines Given by Pharmacists in Oncology Units

Luke Halpern, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 24th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
August 24th 2025

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

Luke Halpern, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 24th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Ibrutinib, Imbruvica tablets | Image Credit: © CLShebley - stock.adobe.com
August 24th 2025

Ibrutinib–Venetoclax Outperforms Ibrutinib Alone and FCR in Long-Term CLL

Alexandra Gerlach, Associate Editor
Hand joints inflammation. Concept of rheumatic arthritis, rheumatism, gout, joint swelling or arthralgia - Image credit: ZAY WIN HTAI | stock.adobe.com
August 24th 2025

FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Close up,asian female doctor with syringe doing injection vaccine,flu,influenza in the shoulder of senior woman, nurse injecting,vaccinating elderly patient,vaccination,medicine,health care concept
August 24th 2025

Patients Express Confidence in Pneumococcal Vaccines Given by Pharmacists in Oncology Units

Luke Halpern, Assistant Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 24th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
August 24th 2025

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

Luke Halpern, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 24th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Ibrutinib, Imbruvica tablets | Image Credit: © CLShebley - stock.adobe.com
August 24th 2025

Ibrutinib–Venetoclax Outperforms Ibrutinib Alone and FCR in Long-Term CLL

Alexandra Gerlach, Associate Editor
Hand joints inflammation. Concept of rheumatic arthritis, rheumatism, gout, joint swelling or arthralgia - Image credit: ZAY WIN HTAI | stock.adobe.com
August 24th 2025

FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.